DIS-CHEM PHARMACIES LIMITED - Dealings in securities

Dealings in securities

Dis-Chem Pharmacies Limited

(Incorporated in the Republic of South Africa)

(Registration number 2005/009766/06)

JSE share code: DCP

ISIN: ZAE000227831

(“Dis-Chem” or the “Company”)


DEALINGS IN DIS-CHEM SHARES BY AN ASSOCIATE OF A PRESCRIBED OFFICER OF THE COMPANY

Shareholders of Dis-Chem are advised of the following dealings in the Company’s securities.

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information is disclosed:


Name of prescribed officer:             Mr Kevin Sterling
Name of associate:                      Kevlu Proprietary Limited, a company owned by the prescribed
                                        officer’s family trust
Nature and extent of interest:          Indirect beneficial
Class of securities:                    Ordinary shares
Nature of transactions:                 On-market disposal of Dis-Chem ordinary shares
Number of shares:                       250 000
Price per security:                     R34.3952
Total value of transaction:             R8 598 800
Date of transaction:                    16 August 2022


Number of shares:                       350 000
Price per security:                     R35.2187
Total value of transaction:             R12 326 545
Date of transaction:                    17 August 2022

Number of shares:                       102 630
Price per security:                     R36.1194
Total value of transaction:             R3 706 934.02
Date of transaction:                   18 August 2022

Clearance for the above transactions were obtained in accordance with Dis-Chem’s trading policy.

By order of the Board
Nikki Lumley
Company Secretary

19 August 2022

Sponsor
The Standard Bank of South Africa Limited

Date: 19-08-2022 03:50:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.